1001
|
|
|
ATPase family AAA domain containing 5 |
C17orf41, ELG1, FRAG1 |
Breast cancer, Cancer, Epithelial ovarian carcinoma, Colorectal cancer, Estrogen-receptor negative breast cancer, Lung cancer, Osteoarthritis, Ovarian cancer, Ovarian serous carcinoma, Peripheral arterial disease, Prostate cancer, Squamous cell carcinoma |
1002
|
|
|
Alpha tubulin acetyltransferase 1 |
C6orf134, MEC17, Nbla00487, TAT, alpha-TAT, alpha-TAT1 |
|
1003
|
|
|
ATCAY kinesin light chain interacting caytaxin |
BNIP-H, CLAC |
|
1004
|
|
|
Arginyltransferase 1 |
- |
Breast cancer, Cancer, Colorectal cancer, Congenital heart disease, Diverticular disease, Dupuytren contracture, Estrogen-receptor negative breast cancer, Lung cancer, Ovarian cancer, Ovarian serous carcinoma, Prostate cancer, Schizophrenia, Squamous cell carcinoma, Hypertension |
1005
|
|
|
Activating transcription factor 1 |
EWS-ATF1, FUS/ATF-1, TREB36 |
|
1006
|
|
|
Activating transcription factor 2 |
CRE-BP1, CREB-2, CREB2, HB16, TREB7 |
|
1007
|
|
|
Activating transcription factor 3 |
- |
Experimental arthritis, Non-small-cell lung carcinoma, Cardiomyopathy, Coronary artery disease, Major depressive disorder, Experimental diabetes, Diabetes mellitus type 2, Hypospadias, Liver cirrhosis, Nervous system disease, Non-neoplastic peripheral nervous system disease, Ovarian neoplasms, Peripheral nervous system disease, Peripheral neuropathy, Prostatic neoplasms |
1008
|
|
|
Activating transcription factor 4 |
CREB-2, CREB2, TAXREB67, TXREB |
|
1009
|
|
|
Activating transcription factor 5 |
ATFX, HMFN0395 |
|
1010
|
|
|
Activating transcription factor 6 |
ACHM7, ATF6A, ATP6alpha |
Achromatopsia, Asbestosis, Color vision deficiency, Cone-rod dystrophy, Congenital nystagmus, Creutzfeldt-jakob disease, Macular dystrophy, Nystagmus, Parkinson disease, Retinitis pigmentosa, Scoliosis, Nonsyndromic hearing loss, Systemic sclerosis |